Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing
This review focuses on the emerging monoclonal antibody market for infectious diseases and the metric ton scale manufacturing requirements to meet global demand. Increasing access to existing antibody-based products coupled with the unmet need in infectious disease will likely exceed the current exi...
সংরক্ষণ করুন:
| প্রধান লেখক: | , |
|---|---|
| বিন্যাস: | গ্রন্থ |
| প্রকাশিত: |
Taylor & Francis Group,
2022-04-01T00:00:00Z.
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | Connect to this object online. |
| ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|
| সংক্ষিপ্ত: | This review focuses on the emerging monoclonal antibody market for infectious diseases and the metric ton scale manufacturing requirements to meet global demand. Increasing access to existing antibody-based products coupled with the unmet need in infectious disease will likely exceed the current existing global manufacturing capacity. Further, the large numbers of individuals infected during epidemics such as the ongoing COVID-19 pandemic emphasizes the need to plan for metric ton manufacturing of monoclonal antibodies by expanding infrastructure and exploring alternative production systems. |
|---|---|
| উপাদানের বিবরণ: | 2164-5515 2164-554X 10.1080/21645515.2021.1930847 |